Site içinde arama yapın

Sophia Sanjay bir ses eklendi Health
2025-10-10 07:22:13 -

The Autoimmune Revolution: Targeted Biologics Transform Chronic Disease Management
The management of Autoimmune Diseases represents a major, sustained application segment for the Biologic Therapy Market, second only to oncology in its clinical impact and commercial value. Autoimmune conditions, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and multiple sclerosis, are chronic, debilitating, and affect millions globally. For decades, treatment relied on...

0 Yorumlar 0 hisse senetleri 302 Views 0 önizleme

Please log in to like, share and comment!
Sophia Sanjay bir ses eklendi Health
2025-10-10 07:22:19 -

The Autoimmune Revolution: Targeted Biologics Transform Chronic Disease Management
The management of Autoimmune Diseases represents a major, sustained application segment for the Biologic Therapy Market, second only to oncology in its clinical impact and commercial value. Autoimmune conditions, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and multiple sclerosis, are chronic, debilitating, and affect millions globally. For decades, treatment relied on...

0 Yorumlar 0 hisse senetleri 314 Views 0 önizleme

Please log in to like, share and comment!
Shiv Mehara bir ses eklendi Other
2025-11-19 11:18:43 -

Autoimmune Polyglandular Syndrome Type 1 Market Forecasted to Reach $363M by 2032
Introspective Market Research (IMR) today announced the release of its Autoimmune Polyglandular Syndrome Type 1 (APS-1) Market Report, projecting a consistent expansion in this rare but clinically significant autoimmune disorder. IMR’s analysis estimates that the APS-1 market — recently valued at USD 289.1 million (2025) according to — will grow to approximately USD...

0 Yorumlar 0 hisse senetleri 36 Views 0 önizleme

Please log in to like, share and comment!